CambReg: Cambridge Regulatory Services

YOUR PARTNER
for a full Regulatory Affairs Service


Main MenuBiosimilar
         
DevalopmentQualityNon-ClinicalClinicalApprovalPost-Approval
CambReg Involvement

 

Clinical Trials

When entering this most costly phase, make sure that you are working with real experts. We will champion your product and remain dedicated to the project until your medicine has reached the market and is benefiting patients.

There are some critical issues to consider in the clinical phase which if ignored will be costly in terms of time.

 

Our Services:

In this busy phase we can help you get ahead by:

• Advising on your Clinical programme

• Managing your CTA (writing and submitting)
• Seeking ethics committee approval
• Recommending opinion leaders
• Recommending a CRO to execute your clinical trial programme
• Arranging Mock GCP inspection
• Preparing Product Information (Labelling and Leaflets)
• User Test Package Leaflets

Critical Issues to be aware of:

Can you substitute confirmatory clinical trials with pharmacodynamic studies?

Have you considered obtaining Scientific Advice from the regulators for your immunogenicity issues?

What impact will the NEW Paediatric Regulation have on your clinical programme?

 

Clinical

Take advantage of our knowledge and experience during this important phase of your product development.

 
 

Working with:UK Trade & Investment Investor in PeopleAsia Manufacturing
© Cambridge Regulatory Services 2010
Site Map
Web Design by Lingo Design

English

Francais

Deutsch

Japan